Company Profile

ALKEM LABORATORIES LTD.

NSE : ALKEMBSE : 539523ISIN CODE : INE540L01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE2274.75-54.1 (-2.32 % )
PREV CLOSE (Rs.) 2328.85
OPEN PRICE (Rs.) 2381.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 862
TODAY'S LOW / HIGH (Rs.)2255.40 2381.00
52 WK LOW / HIGH (Rs.)1660.35 2720
NSE2270.05 -55.8 (-2.4 % )
PREV CLOSE(Rs.) 2325.85
OPEN PRICE (Rs.) 2364.95
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 2270.05 (14 )
VOLUME 43849
TODAY'S LOW / HIGH(Rs.) 2250.45 2364.95
52 WK LOW / HIGH (Rs.)1660 2716.9

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.70
TTM EPS (Rs.) 99.03
P/E Ratio 22.97
Book Value (Rs.) 530.50
Face Value (Rs.) 2
MCap (Rs. in Mn) 271980.48
Price/Earning (TTM) 20.18
Price/Sales (TTM) 4.21
Price/Book (MRQ) 4.29
PAT Margin (%) 13.41
ROCE (%) 17.05
Incorporation Year : 1973

Management Info :

Basudeo N Singh - Chairman Sandeep Singh - Managing Director

Registered Office :

Address : Alkem House,Senapati Bapat Marg,Lower Parel,
Mumbai,
Maharashtra-400013

Phone : 022 3982 9999

Website : www.alkemlabs.com

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS More
16Mar03-16-2020$Alkem Laboratories trades higher on the BSE Alkem Laboratories trades hi

Alkem Laboratories is currently trading at Rs. 2485.75, up by 63.35 points or 2.62% from its previous closing of Rs. 2422.40 on the BSE.

The scrip opened at Rs. 2275.00 and has touched a high and low of Rs. 2526.40 and Rs. 2275.00 respectively. So far 2685 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2720.00 on 19-Feb-2020 and a 52 week low of Rs. 1660.35 on 28-Jun-2019.

Last one week high and low of the scrip stood at Rs. 2640.00 and Rs. 2000.00 respectively. The current market cap of the company is Rs. 29710.71 crore.

The promoters holding in the company stood at 66.04%, while Institutions and Non-Institutions held 14.72% and 19.24% respectively.

The United States Food and Drug Administration (USFDA) has issued an Establishment Inspection Report (EIR) for the Alkem Laboratories’ manufacturing facility located at Baddi, which was inspected from February 17, 2020 to February 21, 2020. The inspection has now been closed by the USFDA.

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.

Alkem Laboratories is currently trading at Rs. 2485.75, up by 6..
13Mar03-13-2020$USFDA issues EIR for Alkem Laboratories’ Baddi facilities USFDA issues EIR for Alkem L

The United States Food and Drug Administration (USFDA) has issued an Establishment Inspection Report (EIR) for the Alkem Laboratories’ manufacturing facility located at Baddi, which was inspected from February 17, 2020 to February 21, 2020. The inspection has now been closed by the USFDA.

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.

The United States Food and Drug Administration (USFDA) has issu..
13Mar03-13-2020$Alkem Laboratories spurts on getting EIR for Baddi facilities Alkem Laboratories spurts on

Alkem Laboratories is currently trading at Rs. 2418.15, up by 36.05 points or 1.51% from its previous closing of Rs. 2382.10 on the BSE.

The scrip opened at Rs. 2250.00 and has touched a high and low of Rs. 2606.95 and Rs. 2000.00 respectively. So far 86626 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2720.00 on 19-Feb-2020 and a 52 week low of Rs. 1660.35 on 28-Jun-2019.

Last one week high and low of the scrip stood at Rs. 2640.00 and Rs. 2000.00 respectively. The current market cap of the company is Rs. 29513.42 crore.

The promoters holding in the company stood at 66.04%, while Institutions and Non-Institutions held 14.72% and 19.24% respectively.

The United States Food and Drug Administration (USFDA) has issued an Establishment Inspection Report (EIR) for the Alkem Laboratories’ manufacturing facility located at Baddi, which was inspected from February 17, 2020 to February 21, 2020. The inspection has now been closed by the USFDA.

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.


Alkem Laboratories is currently trading at Rs. 2418.15, up by 3..
09Mar03-09-2020$Alkem Laboratories informs about expiry of term of independent director Alkem Laboratories informs a

Alkem Laboratories has informed that the tenure of Akhouri Maheshwar Prasad, Independent Director of the Company shall expire on 15th March, 2020, and on completion of his tenure, he shall cease to be the Director on the Board of the Company.

The above information is a part of company’s filings submitted to BSE.

Alkem Laboratories has informed that the tenure of Akhouri Mahe..
22Feb02-22-2020$Alkem Laboratories receives two USFDA observations for Baddi facility in Himachal Alkem Laboratories receives

Alkem Laboratories has received two observations from the US health regulator after inspection of its Baddi facility in Himachal Pradesh. The United States Food and Drug Administration (USFDA) had conducted an inspection at the company's manufacturing facility at Baddi from February 17 to 21, 2020. The company has received a Form 483 with two observations.

The company shall put together a detailed response with adequate corrective and preventive measures to address the observations and the same is proposed to be filed within the timeline stipulated by the US health regulator.

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.

Alkem Laboratories has received two observations from the US he..
Financials More
Rs. in Millions
QTR Dec 19 ANNUAL 19
Net Profit3485.77998.4
Gross Profit 3378 9439.6
Operating Profit 3904.511132.9
Net Sales 1596457140.9
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Sanofi India (BSE)
 6483.75 (3.87%)
M.Cap ( in Cr)
14932.48
Abbott India (BSE)
 15639.50 (1.19%)
M.Cap ( in Cr)
33232.85
Hester Biosciences (BSE)
 951.70 (2.88%)
M.Cap ( in Cr)
809.60
Procter&Gamble Healt (BSE)
 3669.75 (0.69%)
M.Cap ( in Cr)
6091.56
NGL Fine-Chem (BSE)
 274.45 (8.33%)
M.Cap ( in Cr)
169.56
Shareholding Pattern More
MUTUAL FUNDS/UTI 9.04 %
PROMOTERS 66.04 %
FI/BANKS/INSURANCE 2.42 %
NON-INSTITUTION 19.24 %
GOVERNMENT 0.27 %
FII 0 %
F & O Quotes